You run your finger across a raised line on your forearm — the remnant of a childhood bicycle accident — and wonder, for the thousandth time, whether anything can actually be done about it. A friend swears by a cream she saw on Instagram. Your mother tells you to apply vitamin E. The internet offers everything from $12 scar sheets to $5,000 laser procedures, and you have no idea which claims are real and which are marketing dressed up in lab-coat language.

You are asking the right question, and you are far from alone in asking it. Scarring affects virtually every person who has ever had surgery, a significant injury, severe acne, or a burn. In the United States alone, an estimated 100 million patients per year acquire scars from surgical procedures, according to a widely cited analysis published in Wound Repair and Regeneration. Up to 70% of surgical patients report being bothered by their scars, and a third say their scars affect their daily lives — restricting movement, causing itch or pain, or provoking self-consciousness.

The global scar treatment market was valued at approximately $16 billion in 2023, which tells you two things: a lot of people want help with their scars, and a lot of companies want to sell them something. Not all of those products deliver. Some are supported by rigorous randomized controlled trials. Others ride on anecdote, before-and-after photos with convenient lighting differences, and the natural tendency of scars to improve on their own over time — which any product applied during that period can claim credit for.

This article cuts through the noise. We will start with the biology — how wounds heal and why scars form in the first place. We will classify the different types of scars because the type determines the treatment. Then we will walk through every major treatment modality — silicone therapy, corticosteroid injections, laser treatment, microneedling, surgical revision, and over-the-counter products — evaluating each against the published evidence. And we will address something that medical articles too often skip: the real psychological toll that visible scarring takes, and why that matters clinically.

How Wounds Heal — and Why Scars Are the Price

To understand scar treatment, you first need to understand scar formation. Wound healing in humans is a remarkably orchestrated process that unfolds in four overlapping phases, each one setting the stage for the next.

Phase 1: Hemostasis (seconds to hours)

The moment skin is breached, the body prioritizes stopping blood loss. Platelets aggregate at the wound site, forming a clot. This clot serves double duty: it physically plugs the wound and releases growth factors — platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-beta), and others — that recruit the cells needed for the next phase.

Phase 2: Inflammation (hours to days)

Neutrophils arrive within hours, followed by macrophages over the next few days. Their job is to clear bacteria, debris, and dead tissue. Macrophages are particularly important because they also release cytokines and growth factors that signal fibroblasts and endothelial cells to begin repair. This phase causes the redness, swelling, warmth, and pain you recognize as inflammation. It is necessary — without it, wounds do not heal. But excessive or prolonged inflammation is a driver of problematic scarring.

Phase 3: Proliferation (days to weeks)

This is the rebuilding phase. Fibroblasts migrate into the wound and begin producing collagen — the structural protein that gives skin its tensile strength. New blood vessels form (angiogenesis), and the wound contracts as myofibroblasts pull its edges closer together. A temporary matrix of collagen, primarily type III collagen, fills the wound. Keratinocytes proliferate and migrate across the wound surface, re-establishing the epidermal barrier — a process called re-epithelialization.

Phase 4: Remodeling (weeks to years)

The most prolonged phase, lasting anywhere from several weeks to two years or more. During remodeling, the initially disorganized type III collagen is gradually replaced by stronger, more organized type I collagen. The scar matures: it typically becomes flatter, softer, and lighter. However — and this is the critical point — the remodeled tissue never fully recapitulates normal skin. Mature scar tissue achieves only about 80% of the tensile strength of uninjured skin, according to a 2014 review in Advances in Wound Care. It lacks hair follicles, sebaceous glands, and sweat glands. The collagen fibers are arranged in parallel bundles rather than the basket-weave pattern of normal dermis.

This is why scars look and feel different from surrounding skin. And this is why complete scar "removal" — restoring skin to its pre-injury state — is not currently possible. What is possible, and what evidence-based treatments achieve, is significant improvement in a scar's appearance, texture, symptoms, and functional impact.

Scar Types: Why Classification Matters for Treatment

Not all scars are created equal. The type of scar you have fundamentally determines which treatments will help and which will be ineffective or even harmful. There are four major categories.

Hypertrophic Scars

Hypertrophic scars are raised, red, and firm, but they remain within the boundaries of the original wound. They result from excessive collagen production during the proliferative phase but, crucially, the overproduction stays confined. They are most common on the chest, shoulders, upper arms, and knees — areas of high skin tension.

Hypertrophic scars typically appear within 4-8 weeks of injury and often improve spontaneously over 1-2 years, though they may not flatten completely. A 2020 systematic review in the Journal of Plastic, Reconstructive & Aesthetic Surgery reported that hypertrophic scars occur in approximately 40-70% of surgical patients and up to 91% of burn patients, making them the most common form of pathological scarring.

Keloid Scars

Keloids are the most challenging scar type. Like hypertrophic scars, they are raised and firm — but unlike hypertrophic scars, keloids grow beyond the boundaries of the original wound, invading surrounding healthy tissue. They can continue growing for years. They often cause itch, pain, and tenderness. And they have a high recurrence rate after treatment.

Keloids have a strong genetic component. They are significantly more common in people of African, Asian, and Hispanic descent, with prevalence estimates of 6-16% in African populations compared to less than 1% in Caucasian populations, according to a 2017 review in the Journal of Clinical and Aesthetic Dermatology. They occur most frequently on the earlobes, chest, shoulders, and upper back.

The biology of keloids differs from hypertrophic scars in important ways. Keloid fibroblasts produce collagen at a rate up to 20 times higher than normal skin fibroblasts and are resistant to apoptosis (programmed cell death). The TGF-beta signaling pathway is dysregulated, and there is evidence of immune and inflammatory abnormalities that sustain the excessive fibrosis.

Atrophic Scars

Atrophic scars are depressed below the surrounding skin surface — the opposite of hypertrophic scars. They result from destruction of collagen or subcutaneous tissue. The most familiar examples are acne scars, which are further subdivided into ice-pick scars (narrow, deep), rolling scars (broad, undulating), and boxcar scars (broad, sharp-edged). Atrophic scars also result from chickenpox, certain surgical procedures, and inflammatory skin conditions.

Acne scarring affects an estimated 30-40% of people with moderate-to-severe acne, according to a 2019 systematic review in the Journal of the American Academy of Dermatology. It is overwhelmingly associated with delayed or inadequate treatment of active acne — one of the strongest arguments for early, aggressive acne management.

Contracture Scars

Contracture scars form when a large area of skin is damaged, most commonly from burns. The scar tissue contracts as it matures, pulling surrounding skin inward and potentially restricting movement of underlying muscles and joints. Contractures across joints can cause significant functional disability. They often require surgical intervention — not primarily for cosmesis but for restoration of function.

Silicone Therapy: The Gold Standard With Decades of Evidence

If there is a single treatment that occupies the top of every evidence-based scar management guideline, it is silicone. Both silicone gel sheets and topical silicone gel have been studied extensively for over 30 years, and the evidence consistently supports their efficacy for preventing and improving hypertrophic and keloid scars.

Silicone-based scar treatment was first described in the 1980s by researchers in Australia who noticed that burn scars covered by silicone sheets softened and flattened over time. Since then, the evidence base has grown substantially.

A landmark 2020 Cochrane systematic review analyzing 20 randomized controlled trials found that silicone gel sheeting significantly reduced the risk of hypertrophic scarring in people prone to scarring, with a relative risk reduction of approximately 60% when used prophylactically after surgery. The review also found evidence of improvement in existing hypertrophic and keloid scars, though the quality of evidence was rated moderate due to methodological limitations in some included studies.

The International Advisory Panel on Scar Management, in updated consensus guidelines published in Aesthetic Plastic Surgery in 2022, recommends silicone-based products as first-line prophylaxis for patients at elevated risk of hypertrophic or keloid scarring and as first-line treatment for established hypertrophic scars.

How does silicone work? The mechanism is not fully settled, but the leading theory centers on occlusion and hydration. Silicone sheets create an occlusive barrier over the scar that normalizes transepidermal water loss (TEWL) from the scar surface. When the stratum corneum over a scar is immature or absent, TEWL increases dramatically, which signals keratinocytes to produce cytokines that stimulate fibroblasts to overproduce collagen. By normalizing hydration, silicone reduces this signal. A 2013 study in Dermatologic Surgery confirmed that TEWL normalization correlates with scar improvement under silicone therapy.

Practical guidance for silicone therapy:

  • Silicone gel sheets: Apply for a minimum of 12 hours per day (many guidelines recommend 12-24 hours) for at least 3 months. Sheets can be washed and reused for approximately 2-4 weeks each
  • Topical silicone gel: An alternative when sheets are impractical (face, joints, areas with hair). Apply a thin layer twice daily. Evidence suggests similar efficacy to sheets for many scar types
  • Timing: Begin as soon as the wound has fully closed and there are no open areas or sutures. Starting silicone therapy early — within the first month after wound closure — produces better outcomes than delayed treatment
  • Patience: Results are gradual. Expect to see measurable improvement over 8-12 weeks of consistent use, with continued improvement over months

Corticosteroid Injections: The Workhorse for Keloids and Stubborn Hypertrophic Scars

Intralesional corticosteroid injection — most commonly triamcinolone acetonide at concentrations of 10-40 mg/mL — has been a cornerstone of keloid and hypertrophic scar treatment since the 1960s. It remains one of the most effective available treatments, particularly for keloids.

Corticosteroids work on scars through multiple mechanisms: they suppress fibroblast proliferation, reduce collagen synthesis, increase collagenase activity (promoting collagen breakdown), and reduce the inflammatory mediators that drive excessive scarring.

A 2019 meta-analysis in the Journal of the American Academy of Dermatology evaluated the evidence for intralesional corticosteroids across 25 studies and reported a flattening response rate of 50-100% for hypertrophic scars and 50-80% for keloids. However, keloid recurrence after corticosteroid monotherapy remains significant — estimated at 33-50% within 5 years, which is why combination approaches are increasingly preferred.

Common combinations include:

  • Corticosteroid + 5-fluorouracil (5-FU): 5-FU is an antimetabolite that inhibits fibroblast proliferation through a different mechanism than steroids. A 2020 randomized trial in Dermatologic Surgery found that the combination produced significantly greater scar improvement than corticosteroid alone, with fewer steroid-related side effects (skin atrophy, telangiectasia)
  • Corticosteroid + cryotherapy: Intralesional cryotherapy (or spray cryotherapy) followed by injection can enhance drug delivery and add a direct tissue-reducing effect
  • Corticosteroid + post-excision radiation: For recalcitrant keloids, excision followed by immediate superficial radiation therapy, with adjunctive steroid injections during healing, achieves recurrence rates as low as 10-20%, according to a 2021 meta-analysis in Radiotherapy and Oncology

Side effects of intralesional corticosteroids include pain at injection (significant, though mitigable with local anesthetic), skin atrophy (thinning of surrounding skin), telangiectasia (visible small blood vessels), and hypopigmentation — particularly noticeable in darker skin tones. These risks are dose-dependent and tend to occur with higher concentrations or excessive injection volumes.

Treatment typically involves injections every 4-6 weeks for 3-6 sessions, depending on response. Early response — softening and flattening within 2-3 sessions — predicts good outcomes.

Laser Therapy: Precision Light for Scar Remodeling

Laser treatment for scars has matured significantly over the past two decades. Different laser types address different scar problems, and understanding which laser does what prevents unrealistic expectations.

Pulsed Dye Laser (PDL) — For Redness and Early Scars

The 585/595 nm pulsed dye laser targets hemoglobin in blood vessels, making it highly effective for reducing the redness and vascularity of immature hypertrophic scars. A 2017 systematic review in Lasers in Medical Science found that PDL treatment significantly reduced scar redness, pliability, and height compared to untreated controls. PDL is often used as a first-line laser intervention for red, raised scars.

PDL is most effective on scars that are less than 1-2 years old and still erythematous (red). It is less useful for mature, pale scars or for deeply depressed atrophic scars.

Fractional Ablative Lasers — For Texture, Depth, and Atrophic Scars

Fractional CO2 and fractional erbium:YAG lasers create thousands of microscopic columns of thermal injury in the scar tissue, leaving surrounding tissue intact. This triggers a controlled wound-healing response that remodels collagen and can improve scar texture, depth, and pliability.

A 2018 meta-analysis in JAMA Dermatology evaluated fractional ablative laser treatment for atrophic acne scars and found a mean clinical improvement of approximately 50-70% across 24 included studies. The improvement was most pronounced for rolling and boxcar scars; ice-pick scars, being narrow and deep, respond less reliably and often benefit from combination with punch techniques.

For hypertrophic and burn scars, fractional ablative lasers have shown impressive results. A 2019 randomized controlled trial in JAMA Surgery demonstrated that fractional CO2 laser treatment of burn scars produced significant improvements in scar pliability, thickness, and patient satisfaction, with improvements persisting at 12-month follow-up.

Fractional Non-Ablative Lasers — Gentler With Less Downtime

Fractional non-ablative lasers (e.g., 1540 nm erbium:glass, 1550 nm erbium fiber) heat dermal collagen without vaporizing the surface. They produce less dramatic per-session improvement than ablative lasers but have shorter recovery times and fewer side effects. Multiple sessions are typically needed. A 2016 review in Dermatologic Surgery found them useful for mild-to-moderate atrophic scars and as an option for patients who cannot tolerate the downtime of ablative treatment.

What Lasers Cannot Do

Lasers improve scars; they do not erase them. Setting realistic expectations is essential. A scar treated with the best available laser protocol will typically improve by 40-70% — meaningful and often life-changing, but not a return to pre-injury skin. Multiple sessions (typically 3-6, spaced 4-8 weeks apart) are usually needed, and full results develop over months as collagen remodeling continues after the final session.

Microneedling: Controlled Injury for Collagen Induction

Microneedling — also known as percutaneous collagen induction therapy (PCIT) — uses a device studded with fine needles (typically 0.5-2.5 mm in length) to create thousands of tiny puncture wounds in scar tissue. These micro-injuries trigger a cascade of wound healing that produces new collagen and elastin, remodeling the scar from within.

The principle is similar to fractional laser treatment, but the mechanism of injury is mechanical rather than thermal. This distinction has practical implications: microneedling carries a lower risk of post-inflammatory hyperpigmentation (PIH) compared to laser treatment, making it a preferred option for patients with darker skin tones (Fitzpatrick skin types IV-VI) who are at higher risk of laser-induced dyspigmentation.

A 2018 systematic review and meta-analysis in the Journal of Cosmetic Dermatology analyzed 18 studies of microneedling for atrophic acne scars and found a mean improvement of 31-62% in scar severity scores, depending on the device, needle depth, and number of sessions. Results were best for rolling scars, moderate for boxcar scars, and least impressive for deep ice-pick scars — a pattern consistent with the depth of collagen remodeling that microneedling achieves.

Radiofrequency microneedling — devices that deliver radiofrequency energy through insulated needles — combines the mechanical injury of needling with thermal energy in the deeper dermis. A 2021 randomized split-face trial published in Lasers in Surgery and Medicine found that radiofrequency microneedling produced significantly greater improvement in atrophic acne scars compared to standard microneedling alone, with the advantage of minimal epidermal damage.

Practical considerations:

  • Most protocols involve 3-6 sessions spaced 4-6 weeks apart
  • Needle depth is adjusted based on the treatment area and scar type: 0.5-1.0 mm for superficial scars, 1.5-2.5 mm for deeper atrophic scars
  • Downtime is typically 1-3 days of redness and mild swelling — significantly less than fractional ablative laser
  • Platelet-rich plasma (PRP) applied immediately after microneedling has shown synergistic benefit in several studies. A 2019 meta-analysis in Dermatologic Surgery found that microneedling combined with PRP produced significantly greater improvement in acne scars than microneedling alone
  • Home dermarollers (0.2-0.5 mm) can modestly improve product absorption and skin texture but do not reach the depth needed for meaningful scar remodeling. Therapeutic microneedling should be performed by a trained professional

Surgical Scar Revision: When the Scar Itself Needs Rebuilding

Surgical scar revision is not about removing a scar — it is about replacing a poor scar with a better one. It is typically reserved for scars that are functionally problematic (contractures limiting movement), cosmetically severe (wide, depressed, or irregularly oriented scars), or resistant to conservative treatment.

The primary techniques include:

Excision and Re-Closure

The simplest approach: the old scar is surgically removed, and the wound edges are carefully re-approximated with meticulous surgical technique. This works best for wide, flat scars that resulted from poor wound healing, wound tension, or infection. The new scar benefits from controlled conditions — clean wound edges, layered closure to minimize tension, optimal suture technique, and planned post-operative scar management (silicone, pressure).

Z-Plasty and W-Plasty

These geometric rearrangement techniques reorient a linear scar so that it follows natural skin tension lines (relaxed skin tension lines, or RSTLs) more closely. A scar that crosses tension lines perpendicularly tends to widen; reorienting it to lie parallel to tension lines produces a narrower, flatter result. Z-plasty also lengthens contracted scars, making it particularly valuable for burn contractures that restrict joint movement.

Tissue Expansion

For large scars, particularly after burns, a silicone balloon (tissue expander) is placed under adjacent healthy skin and gradually inflated over weeks. The expanded skin is then advanced to cover the scarred area after scar excision. This technique produces a replacement surface of normal, sensation-bearing skin — a major advantage over skin grafting.

Subcision

For depressed atrophic scars — particularly rolling acne scars — subcision involves inserting a needle or blade beneath the scar to sever the fibrous bands tethering it to deeper structures. This releases the scar, allowing it to elevate. A 2020 study in the Journal of Cosmetic Dermatology found that subcision combined with filler injection achieved significant improvement in rolling acne scars compared to subcision alone. Subcision is often combined with other treatments (microneedling, laser, filler) for optimal results.

Keloid Excision — The Challenge of Recurrence

Excising a keloid without adjunctive therapy results in recurrence rates of 45-100% — the surgery itself creates a new wound that the keloid-prone tissue responds to with even more aggressive scarring. This is why keloid excision is almost always combined with adjunctive therapy: intralesional corticosteroids, superficial radiation therapy (SRT), 5-fluorouracil, or silicone sheeting. The combination of excision plus immediate post-operative SRT has the strongest evidence base, with recurrence rates as low as 10% in some series.

Over-the-Counter Scar Products: Separating Evidence From Marketing

The scar treatment aisle is crowded, and the marketing claims are confident. Here is what the evidence actually says about the most commonly promoted ingredients.

Onion Extract (Allium cepa) — e.g., Mederma

Onion extract is the active ingredient in several popular OTC scar products, most notably Mederma. The proposed mechanism involves anti-inflammatory, antiproliferative, and collagen-regulating properties. However, the clinical evidence is mixed at best.

A 2012 randomized controlled trial in the Journal of the American Academy of Dermatology compared onion extract gel to petroleum jelly (an inert occlusive) for post-surgical scar prevention and found no significant difference between the two groups. A 2020 systematic review in Dermatologic Surgery evaluating onion extract across eight clinical trials concluded that the evidence for clinical benefit was "inconsistent and limited by study quality."

The most charitable interpretation is that onion extract may provide marginal benefit through its hydrating and occlusive properties — but those same properties can be achieved with plain silicone gel or even petroleum jelly, both of which have stronger supporting evidence.

Vitamin E — The Persistent Myth

Vitamin E (tocopherol) is perhaps the most widely recommended scar remedy in folk medicine and popular culture. Unfortunately, the scientific evidence does not support its use.

A randomized, double-blind study published in Dermatologic Surgery in 1999 found that topical vitamin E did not improve the cosmetic appearance of surgical scars and that 33% of patients in the vitamin E group developed contact dermatitis — a significant adverse effect. A subsequent 2016 systematic review in the Journal of Plastic, Reconstructive & Aesthetic Surgery analyzed eight studies and concluded that there is "no convincing evidence" that topical vitamin E improves scar outcomes.

Despite this, vitamin E remains one of the most commonly recommended scar remedies by non-dermatologist healthcare providers and the general public. It is a textbook example of a treatment whose popularity is driven by intuitive appeal ("antioxidants are good for skin") rather than clinical evidence.

Cocoa Butter and Bio-Oil

Cocoa butter is another popular home remedy with no meaningful clinical evidence supporting scar improvement. A 2010 randomized controlled trial in pregnancy-related stretch marks (a form of scarring) published in the Journal of Cosmetic Dermatology found cocoa butter performed no better than placebo.

Bio-Oil (mineral oil with vitamins A and E, plus plant extracts) is heavily marketed for scars and stretch marks. While some company-sponsored studies show modest benefit, independent systematic reviews have not found compelling evidence that it outperforms basic emollients.

What Actually Works Over the Counter

The OTC products with genuine evidence are:

  1. Silicone gel or silicone sheets — as discussed, backed by Cochrane review evidence
  2. Petrolatum (petroleum jelly) — an effective occlusive that normalizes TEWL, and a 2018 review in the Journal of the American Academy of Dermatology found it comparable to more expensive scar products for post-procedural wound care
  3. Broad-spectrum sunscreen (SPF 30+) — essential for maturing scars, which are highly susceptible to UV-induced hyperpigmentation. Sun protection does not improve the scar itself but prevents it from becoming permanently darker than surrounding skin

Emerging and Adjunctive Therapies

Beyond the established treatments, several newer approaches are generating promising evidence.

Botulinum Toxin (Botox)

Injecting botulinum toxin around fresh surgical wounds reduces muscle tension on the healing scar — tension being a major driver of scar widening. A 2019 meta-analysis in Plastic and Reconstructive Surgery analyzed nine randomized controlled trials and found that botulinum toxin injection at the time of wound closure significantly improved scar appearance compared to controls, particularly for facial scars.

Pressure Therapy

Pressure garments have been standard-of-care for burn scar management since the 1970s. They work by compressing blood vessels in the scar, reducing oxygen and nutrient delivery to the hypermetabolic scar tissue and downregulating collagen synthesis. A 2017 Cochrane review found that pressure therapy provided modest benefit for burn scar prevention, though the optimal pressure and duration remain debated. Current guidelines recommend wearing pressure garments for 23 hours per day for 6-12 months after burn injury.

Fat Grafting (Lipofilling)

Autologous fat transfer to depressed scars provides both volume replacement and, intriguingly, a regenerative effect. Adipose-derived stem cells in the transferred fat appear to improve scar quality beyond simple volume correction. A 2020 systematic review in Aesthetic Surgery Journal found that fat grafting improved both the appearance and the pliability of adherent and depressed scars, though large-scale randomized trials are still needed.

Bleomycin and Verapamil Injections

For keloids resistant to corticosteroids, intralesional bleomycin (an antineoplastic agent) and verapamil (a calcium channel blocker) have shown promise. A 2020 randomized trial in the British Journal of Dermatology found that intralesional bleomycin achieved 73% reduction in keloid volume at 6 months, comparable to triamcinolone but with fewer side effects such as skin atrophy.

Biologic and Gene-Based Approaches (Investigational)

The frontier of scar research includes therapies targeting specific molecular pathways. Avotermin (recombinant TGF-beta3), though discontinued in late-stage trials, demonstrated the concept that modulating specific growth factors can shift wound healing toward regeneration rather than fibrosis. Current investigational approaches include antisense oligonucleotides targeting connective tissue growth factor (CTGF), small interfering RNA (siRNA) against collagen overproduction pathways, and therapies that aim to reprogram wound healing to mimic fetal wound healing — the phenomenon in which early-gestation fetuses heal without scarring, a process mediated by different TGF-beta isoform ratios and reduced inflammation.

When To Start Treatment — and Why Timing Matters

One of the most important — and most frequently neglected — aspects of scar management is timing. The window of opportunity for influencing scar formation is not unlimited.

The optimal approach follows a timeline:

Immediately After Wound Closure (Weeks 0-2)

  • Keep the wound clean and moist. A 2018 review in Advances in Wound Care confirmed that moist wound healing produces less scarring than allowing wounds to dry out and scab
  • Protect from sun exposure — UV radiation stimulates melanocytes in healing tissue, leading to hyperpigmentation
  • Minimize tension on the wound (surgical tape or adhesive strips can help)
  • Botulinum toxin injection at this stage, if indicated (typically facial scars)

Early Scar Formation (Weeks 2-8)

  • Begin silicone therapy as soon as the wound is fully epithelialized (closed with intact skin surface, no scabs or open areas)
  • Pressure therapy for burn scars
  • Gentle massage — while not supported by robust randomized trials, scar massage is recommended in clinical practice guidelines by multiple professional societies as a low-risk intervention that may improve scar pliability

Active Scar Maturation (Months 2-12)

  • Continue silicone therapy for a minimum of 3 months
  • If the scar is becoming hypertrophic or keloid despite conservative measures, initiate corticosteroid injections promptly — early intervention produces better outcomes than waiting
  • Pulsed dye laser for persistent redness
  • This is the phase where tracking your scar's progress becomes particularly valuable. WatchMyHealth's skin care analysis feature allows you to photograph and document your scar at regular intervals, creating a visual timeline that helps you and your dermatologist assess whether current treatment is working or needs escalation

Mature Scars (12+ Months)

  • Fractional laser resurfacing, microneedling, or surgical revision for scars that have stabilized but remain problematic
  • Combination approaches often produce the best results at this stage
  • Atrophic scars (acne scars) are typically treated during this phase, as active acne must be controlled first

Special Populations and Considerations

Darker Skin Tones

Patients with Fitzpatrick skin types IV-VI face unique challenges in scar management. They are more prone to keloid formation and more susceptible to post-inflammatory hyperpigmentation from both the scar itself and from certain treatments (particularly ablative lasers). A 2021 review in Dermatologic Surgery recommended that practitioners treating scars in darker skin prioritize microneedling and non-ablative fractional lasers over ablative lasers, use lower energy settings, and combine treatments with topical agents (hydroquinone, retinoids, azelaic acid) to manage pigmentary changes.

Pediatric Scars

Children's scars present a paradox: young skin has excellent regenerative capacity, but growing bodies mean that scars may stretch and change over time. Contracture scars across joints are particularly concerning in children because they can restrict growth. Silicone therapy is safe for all ages. Laser treatment and steroid injections are used in children when indicated, with appropriate adjustments.

Pregnancy

Many scar treatments — including laser therapy, intralesional steroids, and most injectable treatments — are contraindicated or unstudied in pregnancy. Silicone sheets and gel are considered safe, as silicone is not absorbed systemically. Sun protection is especially important during pregnancy, as hormonal changes increase melanin production and the risk of scar hyperpigmentation.

The Emotional Weight of Scars

Medical literature has historically treated scars as a cosmetic concern — something that "just" affects appearance. This framing is both clinically wrong and harmful to patients.

A 2016 systematic review in Body Image analyzed 42 studies of scar-related psychological distress and found that visible scarring was associated with significantly elevated rates of anxiety, depression, social avoidance, body image dissatisfaction, and post-traumatic stress symptoms. The psychological impact was not proportional to scar size — even small scars in visible locations (face, hands) could produce substantial distress.

Burn survivors carry a particularly heavy psychological burden. A 2019 study in Burns found that 45% of burn survivors screened positive for clinically significant psychological distress at 12 months post-injury, including depression, anxiety, and PTSD. The distress was correlated with scar visibility but also with functional limitations, pain, and itch — symptoms that are often undertreated.

Facial scars carry unique social consequences. Research in social psychology has demonstrated that people form less favorable first impressions of individuals with facial scars, unconsciously associating scarring with aggression or untrustworthiness — a bias that is both irrational and well-documented. A 2011 study in Plastic and Reconstructive Surgery found that facial scar revision surgery improved not only appearance ratings but also patients' scores on standardized measures of social anxiety and quality of life.

The psychological impact of scarring is not vanity. It is a measurable health outcome that deserves clinical attention. If a scar is causing you distress — affecting your confidence, your social interactions, your willingness to wear certain clothing, or your mental health — that is a legitimate medical reason to seek treatment. You do not need to justify wanting to improve a scar by pointing to functional limitation alone.

WatchMyHealth's mood and wellbeing tracking features can help you identify whether a scar is affecting your emotional state over time. Logging your mood alongside scar treatment progress creates a fuller picture of how treatment is (or is not) improving your overall quality of life — information that matters to both you and your care team.

Building Your Scar Treatment Plan: A Decision Framework

With so many options available, choosing the right approach can feel overwhelming. Here is a simplified decision framework based on current clinical guidelines.

For new surgical or traumatic scars (prevention):

  1. Silicone gel or sheets — start as soon as wound closes
  2. Sun protection — SPF 30+ on exposed scars for at least 12 months
  3. Tension reduction — surgical tape, paper tape across the scar
  4. Monitor for 3-6 months — most scars improve significantly on their own during this period

For hypertrophic scars that are not improving:

  1. Continue silicone therapy
  2. Add intralesional corticosteroid injections (triamcinolone 10-20 mg/mL)
  3. Consider pulsed dye laser for persistent redness
  4. If resistant after 6-12 months, consider fractional laser or surgical revision

For keloids:

  1. Intralesional corticosteroid injections (first-line), often combined with 5-FU
  2. Silicone therapy as adjunct
  3. If resistant, consider excision + immediate radiation therapy
  4. Expect long-term follow-up — keloid management is often ongoing

For atrophic (acne) scars:

  1. Control active acne first — treating scars while acne is active is counterproductive
  2. Microneedling (3-6 sessions) — good first-line, especially for darker skin
  3. Fractional ablative laser for more significant scarring
  4. Subcision + filler for deep rolling scars
  5. Punch excision for deep ice-pick scars

For burn contractures:

  1. Pressure therapy + silicone as first-line
  2. Physical therapy to maintain range of motion
  3. Surgical release (Z-plasty, skin grafting, tissue expansion) for functional limitation

Regardless of scar type, document your starting point. Photograph your scar in consistent lighting, at the same angle, at regular intervals. This is not about obsessing — it is about having objective data. Scars change slowly, and daily observation makes it nearly impossible to perceive gradual improvement. Comparison photos taken weeks or months apart reveal changes that you would otherwise miss.

Key Takeaways

  • Scars are the normal outcome of wound healing — complete removal is not possible, but significant improvement almost always is
  • Scar type determines treatment: hypertrophic, keloid, atrophic, and contracture scars each require different approaches. Misidentifying your scar type leads to ineffective treatment
  • Silicone therapy is the best-supported first-line treatment for hypertrophic and keloid scars, backed by Cochrane review evidence. Start early (as soon as the wound closes) and continue for at least 3 months
  • Corticosteroid injections remain a cornerstone for keloids and stubborn hypertrophic scars, with even better results when combined with 5-fluorouracil or post-excision radiation
  • Laser therapy offers meaningful improvement for both raised scars (pulsed dye laser) and depressed scars (fractional ablative laser), with typical improvement in the 40-70% range over multiple sessions
  • Microneedling is a strong option for atrophic scars, particularly in patients with darker skin who are at higher risk of laser-induced pigmentation changes
  • Vitamin E and onion extract (Mederma) do not have convincing clinical evidence. Silicone gel, petroleum jelly, and sunscreen are the evidence-based OTC options
  • Timing matters: early intervention during the active scar maturation phase (months 2-12) produces better outcomes than delayed treatment of mature scars
  • Keloids are biologically different from hypertrophic scars — they are harder to treat, have high recurrence rates, and usually require combination therapy
  • The emotional impact of scarring is a legitimate health concern, not vanity. Depression, anxiety, and social avoidance are well-documented in people with visible scars
  • No single treatment works for everyone — the best outcomes come from combination approaches tailored to scar type, location, skin tone, and patient goals